Bempedoic acid, an ATP citrate lyase inhibitor, reduces intimal hyperplasia via activation of AMPKα signaling pathway
Source : https://www.sciencedirect.com/science/article/pii/S1567576922008761?via=ihub
* ACLY was firstly demonstrated to be significantly increased in PDGF-BB induced dedifferentiated smooth muscle cells. * * Bempedoic acid significantly reduced ACLY expression and inhibited VSMC dedifferentiation in the...
/>
Conclusions: We demonstrates that bempedoic acid reduces ACLY expression to restrain VSMC proliferation and dedifferentiation by activating AMPK/ACC signaling pathway, which may provide a potential therapeutic strategy for diseases associated with intimal hyperplasia including restenosis and atherosclerosis.
Share
PCSK9 Biomarker and Key Modulator for Cardiovascular Disorders: Heralding a New Therapeutic Era and their Future Perspectives
Source : https://www.eurekaselect.com/article/127987
Cardiovascular disorders (CVDs) are the leading cause of death worldwide and are accelerated via the low level of low-density lipoprotein-cholesterol (LDL-C). The proprotein convertase subtilis/kexin type9 (PCSK9), a vital regulator...
Relevance: This review plays a pivotal role for the researchers and scientists working on PCSK9 inhibitors to treat cardiovascular disorders.
Share
Effect of blood lipids and lipid-lowering therapies on osteoarthritis risk: A Mendelian randomization study
Source : https://www.frontiersin.org/articles/10.3389/fmed.2022.990569/full
BackgroundWe aimed to investigate the effects of blood lipids and lipid-lowering agents on osteoarthritis (OA) risk.Materials and methodsWe performed Mendelian randomization (MR) analyses to estimate the causal effect of blood...
Conclusions: The findings suggested that LDL-C increments have independent protective effects on both knee and hip OA. LDL-C-lowering effects of statins may increase the risk of knee OA.
Share
Safety of PCSK9 inhibitors
Source : https://www.sciencedirect.com/science/article/pii/S0753332222013464?via=ihub
PCSK9 inhibitors do not affect the increase in new cases of diabetes. * Treatment with PCSK9 inhibitors has a lower risk of muscle side effects. * PCSK9 inhibitors do not...
/>
Relevance: The purpose of this review is to summarize information on the safety profile of PCSK9 inhibitors, which may help in making therapeutic decision.
Share
Real-World Data on Comparison of Lipid-Lowering Effects between Alirocumab and Evolocumab in Patients with Hypercholesterolemia - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36440240/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Conclusions: The LDL-C lowering effects of alirocumab are similar to those of evolocumab in clinical practice.
Share
-
Lipid Management Connect3yrKey Points • Source: Acta Cardiologica Sinica • Conclusions: “The LDL-C lowering effects of alirocumab are similar to those of evolocumab in clinical practice.” • Taiwanese researchers compared characteristics, prescribed medications, plasma LDL-C levels, and percentages Show More